mained elevated for up to 2 weeks after ischemia. The temporal profiles of the expression of these genes were different from those of other angiogenic genes such as basic fibrobast growth factor/fibroblast growth factor receptor and vascular endothe lial growth factor/vascular endothelial growth factor receptor and proteolytic enzymes (tissue-type plasminogen activator and urokinase plasminogen activator) and their inhibitors (plasmin ogen activator inhibitor-I), The expression patterns of these genes could be related to progressive tissue liquefaction and neovascularization after ischemia in this stroke model. Differ ential expression of these angiogenesis genes suggests the in volvement of complex regulatory mechanisms that remain to be characterized, Key Words: Angiogenesis-Basic fibroblast growth factor-Vascular endothelial growth factor-Trans forming growth factor-l3t-Tissue plasminogen activator Stroke, arthritis, and psoriasis, Angiogenic activity reflects a bal ance of positive and negative regulators of blood vessel growth, The search for these modulators of angiogenesis has yielded several candidates. However, uncertainty re mains on the specific roles of endogenous mediators of angiogenesis (Pepper, 1996; O'Reilly et aI., 1997; Risau, 1997) .
Tie-l and Tie-2 are receptor tyrosine kinases (RTKs) that are expressed exclusively in the endothelial cell (Mustonen and Alitalo, 1995) . The restricted expression in endothelial cells suggests that the signaling pathways mediated by these RTKs play key roles in vascular func tion. Tie-l and Tie-2 are encoded by distinct genes on chromosome 4. The deduced amino acid sequences of mouse Tie-l and Tie-2 contain 1,134 and 1,122 amino acids, respectively. Sequence analysis of these two re ceptors reveals high sequence conservation in the cyto plasmic region with considerable divergence in the ex tracellular ligand-binding domain (Dumont et aI., 1992; Sato et aI., 1993) . Engineered mutations of mouse genes coding for Tie-I, Tie-2, and some of their ligands result in distinct vascular defects, demonstrating that the sig naling pathways mediated by these RTKs play specific roles in endothelial cell biology (Dumont et aI., 1994; Sato et aI., 1995; Beck and D'Amore, 1997) .
The ligand for the Tie-2 receptor has been cloned and named angiopoietin-l (Angpo-l) (Davis et aI., 1996) . However, ligands for the Tie-l receptor are not presently known. Angiopoietin-l contains 498 amino acids, in cluding an N-terminal secretory signal sequence. Two regions within the coding sequence display homology to myosin and the C-terminus of fibrinogen, respectively. The pattern of Angpo-l expression in the embryo suggests its important role in the developing vascula ture (Davis et aI., 1996; Suri et aI., 1996) . Mice lacking Angpo-1 display a characteristic vascular defect that is distinguished from that caused by vascular endothelial growth factor (VEGF) gene deletion, but they are remi niscent of Tie-2 gene knockout mice (Sato et aI., 1995) . They appear grossly abnormal by embryonic day 11 and die by embryonic day 12.5. Even though the total num ber of endothelial cells seems unaffected, the number of large vessels and their caliber are reduced with fewer and straighter branches than in the wild type. Angiopoietin-2 (Angpo-2) comprises 496 amino acids with a secretion signal peptide and is -60% identical to Angpo-l (Mai sonpierre et aI., 1997) . In contrast to Angpo-1, which stimulates phosphorylation of Tie-2 in a variety of en dothelial cell lines, Angpo-2 fails to elicit the same re sponse. In fact, Angpo-2 blocks Angpo-1 acti vation of the Tie-2 receptor, suggesting that a biological role of Angpo-2 may be to antagonize Angpo-l activation of Tie-2. The Angpo-2-positive cells are likely to be endothelial cells or pericytes (Hirschi and D' Amore, 1996) . Transgenic embryos overexpressing Angpo-2 were found to die on embryonic days 9.5 to 10.5, and the defect in these embryos was similar to that in mice lack ing either Angpo-l or Tie-2 receptor.
The expression of Tie-l and Tie-2 persists in quiescent adult endothelial cells, although at reduced levels in some organs such as the brain and heart (Dumont et aI., 1992) . The expression of Tie-l is increased during matu ration of ovarian follicles, wound healing, and tumor angiogenesis (Hatva et aI., 1994) . However, it is not clear whether the observed Tie-1 expression is a cause or con sequence of neovascularization.
Angiogenesis occurs in the ischemic brain, particu larly in the ischemic penumbra. The extent of angiogen esis has been correlated to survival in stroke patients (Krupinski et aI., 1994) . To our knowledge, expression of Angpo/Tie receptor system genes in the ischemic brain has not been previously reported. The purpose of the present study is to examine ischemi a -induced expres sion of Angpo and Tie receptor mRNA in the brain in relation to other genes that may contribute to angiogen esis.
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Stroke model
The focal cerebral ischemia-reperfusion model in the rat has been described previously (Chen et al., 1986; Lin et aI., 1993) . In brief, male Long-Evans rats weighing 250 to 300 g were anesthetized with chloral hydrate (360 mg/kg body weight, intraperitoneaIIy). The trunk of the right middle cerebral artery (MCA) above the rhinal fissure was identified under a stereo microscope and ligated with a 10-0 suture. Interruption of blood flow distal to ligation was confirmed under the micro scope. Both common carotid arteries were then occluded using nontraumatic aneurysm clips. After 60 minutes of ischemia, the aneurysm clips and the suture were removed and restoration of blood flow in all three arteries was verified. While under an esthesia, the rectal temperature was monitored and maintained at 37.0 ± 0.5°C using a homeothermic blanket (Harvard, Hol liston, MA, U.S.A.). In this model, ischemia for 60 minutes consistently resulted in a large infarct confined to the right MCA cortex (Liu et aI., 1989) . No morphological (Liu et aI., 1989) or biochemical evidence of ischemic brain injury was noted in the left MCA cortex (An et aI., 1993) . After the isch emic insult, rats were kept in an air-ventilated incubator at 24.0 ± 0.5°C for up to 3 weeks and were provided with water and lab chow ad libitum until the end of experiments. At the end of each experiment (30 and 60 minutes after onset of ischemia or 30, 60, 90 minutes, 4, 12 hours, I, 3 days, and I, 2, and 3 weeks after reperfusion), rats were killed by decapitation under anes thesia, and the brain was quickly removed to coIIect the cere bral cortex. The right or left MCA cortices were immediately frozen in liquid nitrogen and stored at -70°C until further pro cessing. The right MCA cortex was also sampled from animals subjected to vascular surgeries without occlusion to serve as sham-operated control. In some experiments, photography of the whole brain was made for gross visual assessment of the extent of angiogenesis. All procedures were approved by our institutional Animal Studies Committee and were in accor dance with the Public Health Service Guide for the Care and Use of Laboratory Animals, USDA Regulations, and the Guidelines of the American Veterinary Medical Association Panel on Euthanasia.
RNA isolation and reverse transcription
Total RNA was isolated from frozen cerebral cortex using the si ngle-step acid guanidinium thiocyanate/phenol/ chloroform extraction method as previously described (An et aI., 1993; Lin et aI., 1996) . Total RNA (1 fLg) was incubated with 200 U of Moloney-Murine Leukemia Virus reverse tran scriptase (RTase; Clontech, Palo Alto, CA, U.S.A.) in a buffer containing a final concentration of 50 mmollL Tris-Cl (pH 8.3), 75 mmollL KCI, 3 mmollL MgClz, 20 U of RNase inhibitor, I fLmol/L polydT oligomer, and 0.5 mmollL of each dNTP in a final volume of 20 fLL. The reaction mixture was incubated at 42°C for I hour and then at 94°C for 5 minutes to inactivate the enzyme, A total of 80 fLL of diethyl pyrocarbonate treated water was added to the reaction mixture before storage at -70°C (Lin et aI., 1998) .
Polymerase chain reaction
Polymerase chain reaction (PCR) primer sequences were chosen from published documents as listed in Table I . In brief, 5 fLL of the reverse transcription (RT) reaction solution was used in the PCR. Polymerase chain reaction was carried out in a final volume of 50 fLL containing 200 fLmollL each of dATP, dCTP, dGTP, and dTTP, 5 pmol of each primer, 1.25 U of Taq polymerase (BRL, Grand Island, NY, U.S.A.), 20 mmollL Tris CI (pH 8.4), 1.5 mmollL MgCI 2 , and 50 mmollL KCI. The Primer sequence (5' -3') Product (bp) Ref.
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mixture was incubated in a thermal cycler for 35 cycles using the following profile: 94°C for 7 minutes, then repeat cycles of 94°C for 45 seconds, 55°C for 45 seconds, and noc for 90 seconds. Samples were then incubated at noc for 7 minutes and cooled to 4°C (GeneAmp 2400, PE, Foster City, CA, U.S.A.) (Lin et aI., 1998) . Polymerase chain reaction products were run on 2% agarose gel for DNA fragment size verifica tion, then eluted and subcloned (Invitrogen, CH Groningen, The Netherlands) for sequence identity (Fig. I) , and served as probe to detect respective mRNA in Northern blot analysis. dium dodecyl sulfate and two 30-minute washes at 60°C in 0.1 x saline/sodium citrate. Membranes were then exposed to Kodak X-Omat/XB-I film. The radioactive bands were quan tified by a densitometer.
Northern blot analysis
Northern blot analysis has been described previously Lin et a!., 1996) . In brief, RNA samples (1 5 ].Lg/lane) were applied to 1.2% agarose gel in the presence of 2.2 mollL formaldehyde. After electrophoresis, gels were transblotted onto Nytran membranes (Gene Screen Plus; Du Pont, Boston, MA, U.S.A.). Membranes were prehybridized at 60°C in a solution containing I % sodium dodecyl sulfate, I mollL NaCI, 10% dextran sulfate, and 100 ].Lg/mL sheared salmon sperm DNA. Reverse transcription PCR-amplified eDNA probes, fi broblast growth factor receptor (FGFR) eDNA (a gift from Dr J. Milbrandt) (Wanaka et a!., 1990) , and glyceraldehyde-3phosphate dehydrogenase cDNA probes (Fort et a!., 1985) were labeled with [3 2 p]dCTP using the random primer labeling method (Amersham, Arlington Heights, IL, U.S.A.). Radioac tive probes (1 x 106 cpm/mL) were added directly to the pre hybridization solution. Following overnight hybridization at 60°C, membranes were washed twice in 2x saline/sodium ci trate at room temperature for 5 minutes each, followed by two 30-minute washes at 60°C in 2x saline/sodium citrate/ 1% so- 
Chemicals
All chemicals were of reagent-grade purity and purchased either from E. Merck (Darmstadt, Denmark) or Sigma Chemi cal Co. (St. Louis, MO, U.S.A.), unless otherwise indicated.
Statistics
One-way analysis of variance was used to compare the tem poral expression of mRNAs. The level of significance for dif ferences between groups was further analyzed with post hoc Fisher-protected t tests using statistical software (GB-STAT 5.0.4; Dynamic Microsystem, Silver Springs, MD, U.S.A.). A P value of <0.05 was considered significant.
RESULTS
Every oligonucleotide sequence pair used for peR amplification resulted in a single cDNA fragment when visualized with ethidium bromide on agarose gel with the respective size shown in Table 1 . A representative peR profile is presented in Fig. 1 (top) . The expression pat tern of Tie-1 mRNA obtained from RT -peR was similar to that derived from Northern blot analysis shown in Fig.  2 . The cDNA fragments derived from peR were eluted and subcloned into peRIl, which provides a one-step cloning strategy for direct inseJ1ion of peR products into plasmid vector (Invitrogen). Each amplified cDNA frag ment was subjected to DNA sequencer analysis (ABI 377, PE) to establish sequence identity in Genbank. Re sults indicate a very high fidelity for peR amplification (data not shown). These cDNA fragments served as probes to detect the respective angiogenesis genes in subsequent studies.
The temporal expression profiles of Angpo-I, Angpo-2, Tie-I, and Tie-2 mRNA following ischemia reperfusion were examined by Northern blot analysis (Fig. 2) . A single species of 4.4-kb Angpo-I transcript in the adult rat brain was recognized by the PeR-amplified probe. Angpo-l mRNA could be detected in the right MeA cortex of sham-operated rats. Induction of An gpo-l mRNA expression in the ischemic right MeA cor tex was delayed, with significant increase noted starting I week (168 hours) after reperfusion. Quantitative analy sis indicated an eightfold increase 2 weeks after ischemia as compared with the sham-operated controls. A single Angpo-2 mRNA species of -2.4-kb size was also de tected in the right MeA cortex of the sham-operated controls. Ischemia increased Angpo-2 mRNA expression in the right MeA cortex. However, the temporal expres sion of Angpo-2 mRNA was different from that of An gpo-I. Significant increase in Angpo-2 mRNA expres sion was observed as early as 12 hours, peaking at 24 hours after ischemia. It declined at 72 hours but remained above basal level. A second peak was noted toward the end of the second week. At its peak, there was a 6.4-fold increase as compared with the sham-operated controls.
The PeR-amplified Tie-I probe recognized a 4.3-kb transcript in the sham-operated controls. Ischemia in- 1, and Tie-2 mRNA expression after focal cerebral ischemia reperfusion. Transient ischemia for 60 minutes resulted in a sig nificant increase in mRNA levels of Angpo-1 (4.4 kb), Angpo-2 (2.4 kb), Tie-1 (4.3 kb), and Tie-2 (4.3 kb) in the ischemic right middle cerebral artery (MeA) cortex. The same blots were sub sequently stripped and rehybridized with glyceraldehyde-3phosphate dehydrogenase to serve as internal controls. The ra dioactive bands were quantified and normalized with those de rived from glyceraldehyde-3-phosphate dehydrogenase mRNA. Value obtained from the sham-operated control was arbitrarily defined as 1. Data were means ± SO from four animals . • P < 0.05, •• P < 0.01, significant differences from the sham-operated controls. Sh denotes sham-operated controls and -0.5 and 0 represent 30 and 60 minutes after onset of ischemia or 30 and 0 minutes before the initiation of reperfusion, respectively. 0.5, 1, 1.5, 4, 12, 24, 72, 168, and 336 denote 0.5, 1, 1.5, 4, 12, 24, 72, 168, and 336 hours of reperfusion following 60 minutes of isch emia, respectively. duced a delayed increase in Tie-l mRNA in the ischemic right MeA cortex starting at 72 hours and peaking at I week after ischemia (l O-fold increase). The Tie-l mRNA levels remained elevated for up to 2 weeks after isch emia. A similar induction profile was noted for a 4.3-kb Tie-2 transcript in the ischemic right MCA cortex. Sig nificant increase in Tie-2 mRNA levels was observed at 24 hours after ischemia and remained at about the same level for up to 2 weeks with peak increase of approxi mately fourfold.
To explore the temporal relation of AngpolTie expres sion with other genes involved in angiogenesis, basic fibroblast growth factor (bFGF), FGFR, VEGF, VEGF receptor-l (VEGFR-I), VEGFR-2, transforming growth factor-� I (TGF-� I ) , plasminogen activator inhibitor-l (PAl -1), tissue-type plasminogen activator (tPA), uroki nase plasminogen activator (uPA), and uPA receptor growth factor (bFGF), fibroblast growth factor receptor (FGFR), vascular endothelial growth factor (VEGF), vascular endothelial growth factor receptor-1 (VEGFR-1), vascular endothelial growth factor receptor-2 (VEGFR-2), transforming growth factor-�1 (TGF-�1)' plasminogen activator inhibitor-1 (PAI-1), tissue-type plasminogen activator (tPA), urokinase plasminogen activator (uPA), and urokinase plasminogen activator receptor (uPAR) mRNA after focal cerebral ischemia-reperfusion in a time course study as described in Fig. 2 . A representative of triplicate experi ments with similar results is shown for each gene.
(uPAR) were also probed by Northern blot analysis (Fig.  3) . The bFGF mRNA was transiently induced and peaked between 12 and 24 hours after ischemia, whereas the expression of FGFR mRNA was delayed, peaking between 3 days and 1 week after ischemia. Similar in duction profiles were obtained using established cDNA or PCR-amplified probes. Unlike bFGF, VEGF mRNA was increased much earlier throughout the ischemic pe riod, extending into the early period of reperfusion. A sharp decrease in VEGF mRNA was noted at 4 hours after ischemia. Interestingly, the level of VEGF mRNA rose again later, peaking at 12 hours after ischemia, and then slowly declined thereafter. It decreased to below preischemic level at 1 week. Two weeks after ischemia, VEGF mRNA was back to the basal level. Very similar temporal profiles were noted for its receptors, VEGFR-l and VEGFR-2, except that both VEGFR-I and VEGFR-2 mRNA peaked at 1 day after ischemia. The PCR-amplified VEGFR-l probe recognized both VEGFR-l (the upper band) and VEGFR-2 (the lower band) mRNA, whereas the PCR-amplified VEGFR-2 probe recognized only VEGFR-2 mRNA. Ischemia caused a delayed induction of TGF-f3, mRNA, peaking at 1 week after ischemia. The PAI-I mRNA was tran siently increased after ischemia, peaking at 1 day. Simi lar to VEGF mRNA, biphasic expression of tPA mRNA was noted peaking at 60 minutes and I day, respectively. Unlike tPA, the induction of uP A mRNA was delayed. It peaked at 1 week. Its receptor, uPAR, mRNA, however, was induced earlier, peaking at 1 day after ischemia. Figure 4 shows the dorsal view of cerebral blood ves sels at various time points (12 hours to 3 weeks) after ischemia as compared with a sham-operated control. Vessel dilatation was noted after 12 hours of reperfusion. Blood vessels were more dilated, with increased vascular density in the ischemic side peaking at 1 week. At 3 weeks after ischemia, the increase in vascular density partially resolved. Brain swelling was noted as early as 12 hours after reperfusion and could be detected by com paring the two hemispheres. Brain swelling appeared to peak at 1 day after ischemia and then gradually subsided. No swelling was noted at 1 week after ischemia. The evolution of brain swelling was similar to that in a pre vious study in which the brain water content (brain edema) was determined from 6 hours to 1 week (Lin et aI., 1993) .
DISCUSSION
Ischemic brain injury is a consequence of severe re duction of blood supply to the affected region. The re sultant low tissue oxygen tension often leads to compen satory neovascularization to meet the metabolic demand (Plate, 1999) . Examples include the development of col lateral blood vessels to the ischemic region and angio genesis in the healing of hypoxic wounds. However, the presumed hypoxia-induced angiogenic factors that me diate this compensatory response have not been fully identified. The putative factors include VEGF and bFGF; both were up-regulated after focal cerebral ischemia with a time course that parallels angiogenesis (Kovacs et aI., 1996; Speliotes et aI., 1996; Hayashi et aI., 1997; Lin et aI., 1997; Cobbs et aI., 1998) . The major cellular origin for bFGF was astrocytes, followed by neurons and en dothelial cells (Lin et aI., 1997) , whereas the cortical neurons and pial cells were the source of VEGF (Hayashi et aI., 1997) .
In addition to VEGF and bFGF, we demonstrate for the first time that cerebral ischemia resulted in the in duction of both Angpo-l and Angpo-2 genes. However, the temporal profiles of their expression were different. The mechanism underlying the differential induction pat terns remains to be determined. During embryogenesis, it has been shown that Angpo-2 may work in concert with VEGF at the front of invading vascular sprouts by blocking the action of constitutively expressed Angpo-l, allowing vessels to remain in a more plastic state in response to the sprouting signal provided by VEGF (Suri et aI., 1996; Maisonpierre et aI., 1997) . In the ab sence of VEGF, Angpo-2 inhibition of constitutive Angpo-l signal may contribute to vessel regression. In  FIG. 4. The effect of focal cerebral ischemia-reperfusion on the vascular density. Rats were subjected to 60-minute ischemia followed by 12 hours (B), 1 day (C), 3 days (0), 1 week (E), and 3 weeks (F) of reperfusion or sham operation (A). The dorsal view of cerebral blood vessels is shown. The upper hemisphere is the control and the lower hemisphere is the ischemic side. Note blood vessels were first enlarged (8 to D), extended (C and D), with increase in vascular density (E), followed by partial resolution toward the basal level (F). i Indicates remodeling of vessels into smaller ones; 6 indicates vessel growing both in length and in width; and ... indicates sprouting angiogenesis.
the present study, the VEGF mRNA induction profile is very similar to that of Angpo-2 mRNA and is in parallel with the evolution of vascular density noted in Fig. 4 . These findings suggest that Angpo-2 could interact with VEGF after ischemic insult, similar to that noted during development. Although Angpo-2 is associated with vessel sprouting, Angpo-l stabilizes the vasculature. The J Cereb Blood Flow Metab. Vol. 20. No.2. 2000 transient increase in Angpo-l mRNA expression and de pression of Angpo-2 mRNA levels during the early phase of ischemia may reflect an initial attempt of the ischemic region to stabilize the vascular integrity. This trend of Angpo-l dominance was reversed later by a decrease in Angpo-l mRNA levels and increase in Angpo-2 expression, peaking at 24 hours, in parallel with VEGF expression. The expression of Angpo-2 and VEGF during the same period may provide a drive for sprouting angiogenesis. The dominance of Angpo-2 was reversed later when a progressive increase in Angpo-l expression was noted late in the angiogenesis process. The dominance of Angpo-l late in vascular remolding is consistent with a shift in the gene expression profile toward vessel stabilization. Assuming the relative domi nance of Angpo-I and Angpo-2 represents vessel stabi lization versus angiogenic sprouting, respectively, the Angpo-l l Angpo-2 ratios over time derived from Fig. 2 (sham-operated control: 1; ischemia 30 minutes: 5; isch emia 60 minutes: 2.23; reperfusion 30 minutes: 1.34; reperfusion 60 minutes: 1.14; reperfusion 90 minutes: 0.89; reperfusion 4 hours: 0.61; reperfusion 12 hours: 0.32; reperfusion 1 day: 0.16; reperfusion 3 days: 0.70; reperfusion 1 week: 1.43; reperfusion 2 weeks: 1.66) appear to reflect very well the evolution of vascular changes noted in Fig. 4 , taking into account a lag in mRNA translation.
Five endothelial cell-specific RTKs have been identi fied (Mustonen and Alitalo, 1995; Beck and D' Amore, 1997) , representing two separate classes of receptors for endothelial cell-specific growth factors (Davis et ai., 1996) . These include Flt-I (or VEGFR-l), Flk-l (VEGFR-2), and Flt-4 (VEGFR-3) receptors. The re maining two are Tie-l and Tie-2 receptors. Results from the present study show that ischemia also led to a de layed and prolonged increase in Tie-2 mRNA levels, which coincides with the induction of its ligands, An gpo-l and Angpo-2. Interestingly, its sib gene, Tie-I, also shared a similar induction profile, indicating a prob able role of this receptor in angiogenesis even though its ligands have yet to be identified. The induction profiles of Tie-l and -2 lagged behind those of VEGFR-I and -2. These findings suggest probable differential roles for these two separate classes of receptors at various stages of vessel remodeling. Incidentally, during embryogen esis, the expression of Tie-l and Tie-2 also follows that of VEGFR-l and VEGFR-2 (Dumont et ai., 1995; Yamaguchi et ai., 1993) . VEGFR-1 and VEGFR-2 are required at the earliest stages of angioblast differentia tion and blood vessel development (Fong et ai., 1995) .
When the temporal expressions of the three angiogen esis genes (Angpo-2, VEGF, and bFGF) are compared, the fluctuation in mRNA levels of these genes follows different courses in the 2 weeks after ischemia. The mo lecular mechanism underlying the differential expression patterns remains to be explored. It is noteworthy that the receptors of these three genes also behave differently. The FGFR mRNA was markedly increased at 3 days and 1 week, whereas VEGFR-l and VEGFR-2 peaked at 24 hours and then declined to below basal level at 1 week. These findings reinforce the contention that Angpo-2, bFGF, and VEGF play different roles in postischemic angiogenesis.
Angiogenic sprouting is accompanied by local degra dation of the vascular basement membrane (Risau, 1997) . Extracellular proteolysis is required for the deg radation of matrix and modulation of cytokine activity during angiogenesis. The expression of TGF-f31 mRNA was delayed, peaking at 1 week. This observation is in agreement with the previously reported TGF-f31 expres sion in a neonatal hypoxia-ischemia model in rats (Klempt et ai., 1992) and a permanent MCA occlusion model in adult rats (Wang et ai., 1995) . Transforming growth factor-f31 may play a modulatory role in angio genesis (Pepper, 1997) , inflammation, and tissue remod eling (Klempt et ai., 1992; Wang et ai., 1995) after isch emic insult. The induction of PAI-l mRNA was tran sient, peaking at I day. Hypoxia stimulates PAI-l expression in an endothelial cell line (Fitzpatrick and Graham, 1998) . High plasma PAI-l levels have also been noted in patients with a history of ischemic stroke (Margaglione et ai., 1994) . To our knowledge, the pres ent study is the first on PAI-1 mRNA expression in the ischemic brain. The expression of uPA mRNA was in duced during the late reperfusion period and peaked at 1 week. Its receptor, uPAR, was elevated at 12 hours and peaked at 24 hours after ischemia. Although an increase in uP A protein level has been reported in a permanent MCA occlusion model (Rosenberg et ai., 1996) , results shown are the first for the expression of uPAR mRNA. Surprisingly, uPAR mRNA was induced earlier than its ligand, uPA mRNA. The mechanism for this unexpected time course is not presently known. Membrane depolar ization induces tPA (Gualandris et aI., 1996) . The induc tion of tPA mRNA after seizure, kindling, and long-term potentiation is reminiscent of immediate early genes (Qian et aI., 1993; Tsirka et aI., 1995) . The tPA levels were elevated after ischemic stroke in patients (Marga glione et aI., 1994) . The expression of tP A mRNA was increased after ischemia in the present study. The ex tended expression of proteases tP A and uP A was in con trast to a transient increase in protease inhibitors such as PAl -1. These results suggest an imbalance in the post ischemic expression of proteases relative to their inhibi tors, a probable mechanism for the liquefaction of the infarcted region weeks after ischemia. Pharmacological inhibition of protease activity has many effects on an giogenesis, and ischemic outcomes remain to be ex plored (Rosenberg et aI., 1996 (Rosenberg et aI., , 1998 .
Neovascularization is accomplished via the concerted efforts of two major cellular processes. The first is vas culogenesis, a de novo synthesis of endothelial cells from either angioblasts or hemangioblasts. The second is an giogenesis, the growth or derivation of vascular struc tures from preexisting vessels (Risau and Flamme, 1995) . Three forms of angiogenesis have been charac-terized: (1) remodeling of vessels into smaller ones (in tussusceptive vascular growth); (2) endothelialization of a vessel that is growing both in length and in width; and (3) sprouting angiogenesis. Sprouting angiogenesis is the most common process in vascular remodeling. After ischemia, all three forms of angiogenesis were noted in the ischemic cerebral cortex at various times. Angiogenic sprouting appears to be the most prominent feature in the present study. Interestingly, Patt et al. (1997) reported a significant increase in both vessel density and size fol lowing severe chronic hypoxia. In the present study, we noted eventual decline in angiogenic sprouting at 3 weeks after ischemia (Fig. 4) . Whether enhancing and/or prolonging angiogenic sprouting will affect the ischemic outcome remains to be studied.
In summary, our data demonstrate for the first time that ischemia differentially regulated the induction of Angpo-l , Angpo-2, Tie-I, and Tie-2 at mRNA levels. The Angpo-lIAngpo-2 ratio appears to be a potentially useful index of the activity of vascular remodeling. Al though expressions of bFGF, VEGF, and Angpo-2 mRNA were all increased after ischemic insult, each showed a characteristic temporal profile. Furthermore, their respective receptors also exhibited different expres sion patterns. Together, these three angiogenic factors and their receptors may play different roles at different stages of the postischemic angiogenic process.
